A natural choice for hemophilia B

0Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Crudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that induced immune tolerance to factor IX (FIX) in a hemophilia B (HB) dog with previously formed anti-FIX inhibitor antibodies (IAs).1

Cite

CITATION STYLE

APA

Koeberl, D. D. (2015, March 5). A natural choice for hemophilia B. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-01-622506

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free